Doctor profile · Federal record
Dr. April Erwin, MD
Neurology Physician (CMS: Neurology) · Internal Medicine Physician · Salt Lake City, UT
- NPI 1194976670
- Accepts Medicare
- MIPS 75.8 / 100 · 2023
- 19 yrs in practice
- Licensed in 2 states
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
370 E 9Th Ave Ste 106
Salt Lake City, UT 841033182
(801) 408-5700
fax (801) 408-5704
Credentials & registration
- NPI registered
- October 2008 — 18 yrs on file
- Profile last updated
- August 26, 2025
- Year of graduation
- 2007 — 19 yrs since
- Specialty taxonomy
- 2084N0400X — NUCC code
- State licenses (2)
- Louisiana #MD.205310 · District of Columbia #MD037611
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1194976670. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
56,692
Distinct HCPCS
10
Medicare allowed
$1,468,974
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J2323 |
Injection, natalizumab, 1 mg | 50,718 | 81 | $23 | |
J2350 |
Injection, ocrelizumab, 1 mg | 5,403 | 13 | $47 | |
96365 |
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 182 | 75 | $60 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 148 | 125 | $119 | |
J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg | 79 | 22 | $4 | |
96375 |
Injection of additional new drug or substance into vein | 34 | 23 | $13 | |
96415 |
Administration of chemotherapy into vein, each additional hour | 31 | 15 | $25 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 29 | 25 | $81 | |
J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) | 26 | 18 | $1 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 15 | 13 | $87 |
In context: peer comparison
Among 26 peers in this city , average services per provider: 1,206. This provider delivers 47× the peer median.Open Payments
Industry payments received
All-time total
$41,748
Transactions
244
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| EMD Serono, Inc. | 37 | $18,947.37 | |
| GENZYME CORPORATION | 11 | $12,109.80 | |
| TG Therapeutics, Inc. | 27 | $7,817.63 | |
| ABBVIE INC. | 40 | $568.39 | |
| Novartis Pharmaceuticals Corporation | 54 | $542.21 | |
| Biogen, Inc. | 17 | $317.20 | |
| Celgene Corporation | 20 | $215.03 | |
| Amgen Inc. | 12 | $154.52 | |
| ARGENX US, INC. | 6 | $141.81 | |
| Genentech USA, Inc. | 7 | $113.37 | |
| UCB, Inc. | 3 | $77.25 | |
| Mallinckrodt Hospital Products Inc. | 2 | $67.35 | |
| PFIZER INC. | 4 | $57.30 | |
| Genentech, Inc. | 2 | $53.36 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $51.96 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,277
Patients
437
Total drug cost
$875,807
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Gabapentin | Generic | 204 | 81 | $4,349 |
| Baclofen | Generic | 191 | 76 | $6,910 |
| Memantine Hcl | Generic | 150 | 51 | $4,702 |
| Dimethyl Fumarate | Generic | 86 | 18 | $100,446 |
| Dalfampridine Er (Dalfampridine) | Brand | 83 | 21 | $46,445 |
| Duloxetine Hcl | Generic | 81 | 22 | $2,983 |
| Kesimpta Pen (Ofatumumab) | Brand | 73 | 13 | $693,562 |
| Donepezil Hcl | Generic | 68 | 27 | $2,485 |
| Amitriptyline Hcl | Generic | 67 | 23 | $1,034 |
| Pregabalin | Generic | 58 | 22 | $2,500 |
Hospital affiliations
Frequently asked questions
What is Dr. April Erwin's medical specialty?
Dr. April Erwin practices Neurology Physician in Salt Lake City, UT.
Where does Dr. April Erwin practice?
Dr. April Erwin practices at 370 E 9Th Ave Ste 106, Salt Lake City, UT 841033182. Office phone: 8014085700.
What is Dr. April Erwin's NPI?
Dr. April Erwin's National Provider Identifier (NPI) is 1194976670, issued by NPPES.
Does Dr. April Erwin accept Medicare assignment?
Yes. Dr. April Erwin accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. April Erwin commonly perform?
Top Medicare-reported procedures in 2023: Injection, natalizumab, 1 mg (HCPCS J2323); Injection, ocrelizumab, 1 mg (HCPCS J2350); Infusion into a vein for therapy, prevention, or diagnosis (HCPCS 96365). Source: CMS Medicare Physician & Other Practitioners file.